phrykt

Genmab A/S (GMAB): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of GMAB were reported in the last 12 months. 6 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Genmab A/S

From the latest filings

Overall: about as much buying as selling. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns GMAB

291 funds and institutions reported GMAB shares worth $2.8B at the end of Q2 2026. The largest holder is Paradigm Biocapital Advisors LP with $361M.

10 largest owners, by value

Paradigm Biocapital Advisors LP$361M
Orbis Allan Gray Ltd$312M
Alliancebernstein L.P.$232M
Deerfield Management Company, L.P.$189M
Deep Track Capital, LP$155M
Arrowstreet Capital, Limited Partnership$137M
BlackRock, Inc.$128M
Sofinnova Investments, Inc.$111M
Renaissance Technologies LLC$96.6M
Two Sigma Investments, LP$96.3M

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Paradigm Biocapital Advisors LP13.13M–$361M+65%
Orbis Allan Gray Ltd11.37M–$312M-12%
Alliancebernstein L.P.8.64M–$232M-10%
Deerfield Management Company, L.P.6.87M–$189M+179%
Deep Track Capital, LP5.65M–$155M+54%
Arrowstreet Capital, Limited Partnership4.98M–$137MNo change
BlackRock, Inc.4.67M–$128M+3%
Sofinnova Investments, Inc.4.05M–$111M+438%
Renaissance Technologies LLC3.52M–$96.6M-20%
Two Sigma Investments, LP3.51M–$96.3M+50%
Harding Loevner LP3.09M–$86.9M-4%
First Trust Advisors LP2.76M–$75.7M+12%
Citadel Advisors LLC2.48M–$68M–
Qube Research & Technologies Ltd1.69M–$46.4M+149%
Morgan Stanley1.63M–$44.8M-25%
Federated Hermes, Inc.1.45M–$39.8M+16%
Goldman Sachs Group Inc1.28M–$35.1M+37%
Franklin Resources Inc1.20M–$33M+1%
Pictet Asset Management Holding SA1.07M–$29.3M-1%
UBS Group AG961,053–$26.4M+222%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No GMAB insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

GMAB short interest

9.66M GMAB shares are sold short. Over the last 12 reports the number of shares short went down 5%.

As of Oct 30, 2026, 9.66M GMAB shares were sold short, up 46.4% from the report before. At the average daily volume of 7.82M shares, buying them all back would take about 1.2 trading days (days to cover).

Shares short

9.66MMay 15Oct 3010.95M

Days to cover

1.2May 15Oct 306.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20269.66M–+46%7.82M1.2
Oct 15, 20266.60M–+9%4.93M1.3
Sep 30, 20266.06M–+23%2.89M2.1
Sep 15, 20264.92M–-28%1.55M3.2
Aug 31, 20266.83M–-10%2.80M2.4
Aug 14, 20267.60M–+3%2.79M2.7
Jul 31, 20267.39M–-2%1.60M4.6
Jul 15, 20267.56M–-9%2.39M3.2
Jun 30, 20268.33M–-3%1.78M4.7
Jun 15, 20268.59M–-15%1.47M5.8
May 29, 202610.05M–-1%2.20M4.6
May 15, 202610.16M–+20%2.09M4.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded GMAB

Since Nov 17, 2024, 2 members of Congress reported 2 purchases and 1 sale of GMAB. The latest was a purchase by Alan Armstrong on Mar 30, 2026, reported Jul 21, 2026.

Purchases 2Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Mar 30, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Jan 16, 2025Josh Gottheimer (D-NJ)Purchase$1K–$15KJointFeb 10, 2025Report
Dec 16, 2024Josh Gottheimer (D-NJ)Sale$1K–$15KJointJan 14, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Famous investors that hold GMAB

6 of the 50 well-known investors we track reported holding GMAB in their latest 13F filing. The largest position is Steve Cohen's, worth $126M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Steve Cohen · Point72 Asset ManagementQ3 20263.54M$126M0.2%+2506%
Jim Simons · Renaissance TechnologiesQ3 20262.27M$81.1M0.1%-35%
Ken Griffin · Citadel AdvisorsQ3 20261.73M$61.7M0.0%-30%
Israel Englander · Millennium ManagementQ3 2026756,496$27M0.0%-17%
Lee Ainslie · Maverick CapitalQ3 202610,683$381K0.0%New
Jeremy Grantham · GMOQ3 20267,563$270K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named GMAB in the last 120 days.

FiledHolderFormStake
Nov 16, 2026ORBIS INVESTMENT MANAGEMENT LTD13G/A4.6%
Nov 16, 2026ORBIS INVESTMENT MANAGEMENT LTD13G/A4.6%
Oct 5, 2026Darwin Global Management, Ltd.13G5.9%
Oct 5, 2026Darwin Global Management, Ltd.13G5.9%

Questions about Genmab A/S (GMAB) stock

Who owns the most GMAB stock?

The largest reported owner of Genmab A/S (GMAB) is Paradigm Biocapital Advisors LP. In total, 291 funds and institutions reported holding GMAB at the end of Q2 2026. See the largest owners.

Are GMAB insiders buying or selling?

No GMAB insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in GMAB?

As of Oct 30, 2026, 9.66M GMAB shares were sold short, up 46.4% from the report before. At the average daily volume of 7.82M shares, buying them all back would take about 1.2 trading days (days to cover). See the history.

Have members of Congress traded GMAB?

Yes. 2 members of Congress reported 2 purchases and 1 sale of GMAB since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.

Which famous investors hold GMAB?

6 of the 50 well-known investors we track reported GMAB in their latest 13F filing, including Steve Cohen, Jim Simons, Ken Griffin. The largest position is worth $126M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.